Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SERO is a Norwegian in vitro diagnostics and laboratory quality company focused on developing, manufacturing, and marketing independent quality control materials for medical laboratories. Founded in 1963, the company specializes in QC products used in clinical chemistry and immunochemistry to help laboratories generate reliable and comparable test results. Its best-known product family includes Seronorm and related control materials covering analytes such as hormones, cardiac markers, tumor markers, diabetes markers, trace elements, lipids, drugs, and other laboratory medicine parameters. SERO operates an ISO 13485-certified facility near Oslo and exports the majority of its products to more than 60 countries through direct sales in the Nordics and distributor networks internationally. The company is not a therapeutics developer; it is a commercial diagnostics tools and controls business serving clinical labs and IVD partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SERO.